Literature DB >> 16631604

Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity.

Kanaklata Roy1, Lilin Wang, G Mike Makrigiorgos, Brendan D Price.   

Abstract

Glioblastomas are among the malignancies most resistant to radiation therapy. In contrast, cells lacking the ATM protein are highly sensitive to ionizing radiation. The relationship between ATM protein expression and radiosensitivity in 3 glioma cell lines was examined. T98G cells exhibited normal levels of ATM protein, whereas U118 and U87 cells had significantly lower levels of ATM and increased (>2-fold) sensitivity to ionizing radiation compared to T98G cells. The ATM promoter was methylated in U87 cells. Demethylation by azacytidine treatment increased ATM protein levels in the U87 cells and decreased their radiosensitivity. In contrast, the ATM promoter in U118 cells was not methylated. Further, expression of exogenous ATM did not significantly alter the radiosensitivity of U118 cells. ATM expression is therefore heterogeneous in the glioma cells examined. In conclusion, methylation of the ATM promoter may account for the variable radiosensitivity and heterogeneous ATM expression in a fraction of glioma cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631604     DOI: 10.1016/j.bbrc.2006.03.222

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.

Authors:  P Mehdipour; F Karami; Firouzeh Javan; M Mehrazin
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors.

Authors:  Xiaofei Chen; Liang Liu; Jade Mims; Elizabeth C Punska; Kristin E Williams; Weiling Zhao; Kathleen F Arcaro; Allen W Tsang; Xiaobo Zhou; Cristina M Furdui
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

3.  The methylation of a panel of genes differentiates low-grade from high-grade gliomas.

Authors:  Aleksandra Majchrzak-Celińska; Jarosław Paluszczak; Marlena Szalata; Anna-Maria Barciszewska; Stanisław Nowak; Robert Kleszcz; Adam Sherba; Wanda Baer-Dubowska
Journal:  Tumour Biol       Date:  2015-01-08

4.  Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma.

Authors:  Weir-Chiang You; Shiow-Her Chiou; Chih-Yang Huang; Shu-Fen Chiang; Cheng-Lin Yang; Janaki N Sudhakar; Tze-Yi Lin; I-Ping Chiang; Chiung-Chyi Shen; Wen-Yu Cheng; Jin-Chin Lin; Shwn-Huey Shieh; Kuan-Chih Chow
Journal:  Neuro Oncol       Date:  2013-10       Impact factor: 12.300

5.  Detection of genomic DNA methylation with denaturing high performance liquid chromatography.

Authors:  Romaica A Omaruddin; M Ahmad Chaudhry
Journal:  Hum Cell       Date:  2010-05       Impact factor: 4.174

6.  ATM is down-regulated by N-Myc-regulated microRNA-421.

Authors:  Hailiang Hu; Liutao Du; Gindy Nagabayashi; Robert C Seeger; Richard A Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 7.  DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art.

Authors:  Frank Roossink; Steven de Jong; G Bea A Wisman; Ate G J van der Zee; Ed Schuuring
Journal:  Cell Oncol (Dordr)       Date:  2012-07-27       Impact factor: 6.730

8.  Novel Ser/Thr protein phosphatase 5 (PP5) regulated targets during DNA damage identified by proteomics analysis.

Authors:  Bryan M Ham; Hemalatha Jayachandran; Feng Yang; Navdeep Jaitly; Ashoka D Polpitiya; Matthew E Monroe; Ling Wang; Rui Zhao; Samuel O Purvine; Eric A Livesay; David G Camp; Sandra Rossie; Richard D Smith
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

9.  Modulation of HJURP (Holliday Junction-Recognizing Protein) levels is correlated with glioblastoma cells survival.

Authors:  Valeria Valente; Rodolfo Bortolozo Serafim; Leonardo Cesar de Oliveira; Fernando Soares Adorni; Raul Torrieri; Daniela Pretti da Cunha Tirapelli; Enilza Maria Espreafico; Sueli Mieko Oba-Shinjo; Suely Kazue Nagahashi Marie; Maria Luisa Paçó-Larson; Carlos Gilberto Carlotti
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

10.  ATM-dependent MiR-335 targets CtIP and modulates the DNA damage response.

Authors:  Nathan T Martin; Kotoka Nakamura; Robert Davies; Shareef A Nahas; Christina Brown; Rashmi Tunuguntla; Richard A Gatti; Hailiang Hu
Journal:  PLoS Genet       Date:  2013-05-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.